---
layout: post
title: 'USAN Watch: January 2013'
date: '2013-01-17T14:41:00.001Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-01-20T14:25:27.467Z'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-3867686885234007096
blogger_orig_url: http://chembl.blogspot.com/2013/01/usan-watch-january-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for January 2013 have recently been published.</span><br />
<br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Structure</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/cebranopadol.pdf">cebranopadol</a></td><td>GRT-6005</td><td><br /></td><td>synthetic small molecule</td><td>therapeutic</td><td>NMDAR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/cobimetinib.pdf">cobimetinib</a>, <a href="http://www.ama-assn.org/resources/doc/usan/cobimetinib-butyrate.pdf">cobimetinib butyrate</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
RG-7420, GDC-973<br />
<br />
<table border="1"><tbody>
</tbody></table>
</div>
</div>
</div>
</td><td><br /></td><td>synthetic small molecule</td><td>therapeutic</td><td>MEK</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/dexmecamylamine.pdf">dexmecamylamine</a>, <a href="http://www.ama-assn.org/resources/doc/usan/dexmecamylamine-hydrochloride.pdf">dexmecamylamine hydrochloride</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
TC-5214, NIH-11008</div>
</div>
</div>
</td><td><div class="separator" style="clear: both; text-align: center;">
<br /></div>
<br /></td><td>synthetic small molecule</td><td>therapeutic</td><td>nAChR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/fluralaner.pdf">fluralaner</a></td><td>A-1443, AH-252723</td><td><br /></td><td>synthetic small molecule</td><td>therapeutic</td><td>?</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/imgatuzumab.pdf">imgatuzumab</a></td><td>GA-201, RG-7160, RO-5083945, HuMAB<egfr></egfr></td><td><br /></td><td>monoclonal antibody</td><td>therapeutic</td><td>EGFR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lampalizumab.pdf">lampalizumab</a></td><td>RG-7417, FCFD-4514S, Anti-fD</td><td><br /></td><td>monoclonal antibody&nbsp;</td><td>therapeutic</td><td>Factor D</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/latanoprostene-bunod.pdf">latanoprostene bunod</a></td><td>NCX-116,&nbsp;<span style="background-color: white; text-align: justify;"><span style="font-family: inherit;">BOL-303259-X</span></span></td><td><br /></td><td>natural product-derived small molecule</td><td>therapeutic</td><td>PGF2R</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/lirilumab.pdf">lirilumab</a></td><td>BMS-986015, IPH-2102</td><td><br /></td><td>monoclonal antibody</td><td>therapeutic</td><td>KIR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/tafenoquine.pdf">tafenoquine</a>, <a href="http://www.ama-assn.org/resources/doc/usan/tafenoquine-succinate.pdf">tafenoquine succinate</a></td><td>SB-252263-AAB, SB-252263-AX, WR-238605</td><td><br /></td><td>synthetic small molecule</td><td>therapeutic</td><td>n/a</td></tr>
</tbody></table>
<br />
<div>
jpo</div>
